الدكتور عادل محمد جبريل خبير في علاج أمراض المناعة الذاتية المعقدة ولديه خبرة واسعة في التهاب المفاصل الروماتويدي وهشاشة العظام والتهاب الفقار اللاصق. وهو يجيد اللغات العربية والإنجليزية والروسية وحاصل على بكالوريوس الطب والجراحة ، دكتوراه في الطب ، دكتوراه ، FACRM ، ACPM ، AAP ، UFR ، SH.
اقرأ المزيدالدكتور فيفيك شارما هو جراح ذو خبرة في جراحة استبدال العظام والمفاصل مع أكثر من 14 عامًا من الخبرة. وهو جراح مؤهل لـ D.Ortho و DNB وقد أجرى أكثر من 5000 عملية جراحية معقدة ومراجعة. لديه خبرة في إجراء تقويم مفاصل الورك / الركبة الأساسي والمراجعة ، وقطع عظم الركبة ، بالإضافة إلى علاج هشاشة العظام والتهاب المفاصل والألم. وهو أيضًا عضو مؤسس في مركز التميز في راجستان.
اقرأ المزيدDr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: